Aardvark Therapeutics, Inc. - Common Stock (NQ:AARD)
5.745
+0.105
(+1.86%)
Streaming Delayed Price
Updated: 11:52 AM EST, Mar 5, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 212,399 |
| Open | 5.590 |
| Bid (Size) | 5.710 (200) |
| Ask (Size) | 5.780 (200) |
| Prev. Close | 5.640 |
| Today's Range | 5.500 - 5.990 |
| 52wk Range | 4.740 - 17.94 |
| Shares Outstanding | N/A |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Monday's session: top gainers and losers ↗
March 02, 2026
Top movers in Friday's after hours session ↗
February 27, 2026
Aardvark Therapeutics Announces Leadership Appointments
February 12, 2026
Let's take a look at the stocks that are in motion in today's session. ↗
December 03, 2025
These stocks are moving in today's session ↗
December 03, 2025
Which stocks are gapping on Wednesday? ↗
December 03, 2025
Which stocks are moving after the closing bell on Tuesday? ↗
December 02, 2025
Frequently Asked Questions
Is Aardvark Therapeutics, Inc. - Common Stock publicly traded?
Yes, Aardvark Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Aardvark Therapeutics, Inc. - Common Stock trade on?
Aardvark Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Aardvark Therapeutics, Inc. - Common Stock?
The ticker symbol for Aardvark Therapeutics, Inc. - Common Stock is AARD on the Nasdaq Stock Market
What is the current price of Aardvark Therapeutics, Inc. - Common Stock?
The current price of Aardvark Therapeutics, Inc. - Common Stock is 5.745
When was Aardvark Therapeutics, Inc. - Common Stock last traded?
The last trade of Aardvark Therapeutics, Inc. - Common Stock was at 03/05/26 11:52 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
Facebook
Twitter
YouTube